Close Menu

Beckman Coulter

The company said that it anticipates regulatory approval from the European Commission on or about June 16 and to close the acquisition by the end of the month.

The company's Clinical Diagnostics segment was up 3 percent year over year, while Life Science slid 11 percent.

The trials will evaluate biomarker panels for lung, colon, and prostate cancer, and may include a comparison of proteomics-based lung cancer tests from Somalogic and Celera.

The deadline for the deal has been pushed back to April 27 from March 23.

In a research note, Jon Groberg wrote that in the near term firms with a larger consumables presence in Japan face greater revenue risk, while instrument firms face greater mid-term risk.

The firms have said they expect to complete the transaction in the first half of this year.

Robert Friel today denied a report that the company is seeking a buyer after failing to land Beckman Coulter.

Shares of PerkinElmer climbed more than 9 percent on Thursday after a report was published saying that the firm is exploring being bought out amid a failed bid to acquire Beckman Coulter.

The company, which is being purchased by Danaher, did not report its earnings for the fourth quarter, but based on what it had previously reported for the first three quarters, revenues for the final quarter of 2010 were $986.5 million.

At the Association for Mass Spectrometry's Applications to the Clinical Lab meeting this week, proteomics researchers highlighted the need for higher-throughput assays, with several introducing automated SISCAPA workflows employing instruments from vendors including Agilent Technologies and Thermo Fisher Scientific.

Pages

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.